Releasing a vaccine to the public where it can make a positive impact on public health and individual lives is a complex process. Quality control testing is critical at every stage, from initial development to full-scale production, to make sure vaccines are as safe as possible.
As infectious diseases evolve, the medical community has been working to meet the challenge by updating and improving the tools we use to combat infections. Right now, biopharmaceutical research companies have 421 medicines and vaccines in development to treat or prevent fungal, bacterial, and viral infections.
Antimicrobial resistance is a crisis that we must tackle with technologies built specifically to address its unique challenges. Clinical informatics software can play an important role in providing hospitals and labs with infectious disease data and insights, including visibility to the value and role of diagnostic tools in supporting antimicrobial stewardship.